IR is a condition in which a particular concentration of insulin produces a less-than-expected biological effect; that makes up a broad clinical spectrum including diabetes, obesity, and metabolic syndrome, which will affect the patient's quality of life (Fig. 3) [25]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.